Subscribe
Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

JAMA Editor’s Summary

Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

May 09, 2017 edition of the weekly JAMA Editors' Summary
May 9, 2017

Selumetinib for lung cancer, postmarket drug safety, screening for thyroid cancer, and more

May 09, 2017 edition of the weekly JAMA Editors’ Summary

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Proudly supported by:

cover
Check out 'The Podcast by KevinMD'! Meet Charles E. Binkley, MD as he and Kevin discuss ethical dilemmas in the pandemic era.